Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Death-Associated Protein Kinase 3 (DAPK3) (N-Term) Peptid

DAPK3 Reaktivität: Human Wirt: Synthetic BP
Produktnummer ABIN8098690
168,15 €
Zzgl. Versandkosten 20,00 € und MwSt
100 μg
Lieferung nach: Deutschland
Lieferung in 6 bis 9 Werktagen

Kurzübersicht für Death-Associated Protein Kinase 3 (DAPK3) (N-Term) Peptid (ABIN8098690)

Target

DAPK3 (Death-Associated Protein Kinase 3 (DAPK3))

Spezies

Human

Quelle

  • 7
Synthetic

Applikation

Blocking Peptide (BP)
  • Protein Region

    N-Term

    Verwendungszweck

    DAPK3 Peptide - N-terminal region

    Sequenz

    EDVEDHYEMG EELGSGQFAI VRKCRQKGTG KEYAAKFIKK RRLSSSRRGV
  • Applikationshinweise

    Optimal working dilution should be determined by the investigator.

    Kommentare

    This is a synthetic peptide designed for use in combination with anti- DAPK3 Antibody (ARP80254_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Lyophilized

    Rekonstitution

    Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Buffer

    Lyophilized powder

    Lagerung

    -20 °C

    Informationen zur Lagerung

    For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
  • Target

    DAPK3 (Death-Associated Protein Kinase 3 (DAPK3))

    Hintergrund

    Background Information: Death-associated protein kinase 3 (DAPK3) induces morphological changes in apoptosis when overexpressed in mammalian cells. These results suggest that DAPK3 may play a role in the induction of apoptosis.

    Alternative Symbols: DLK, ZIP, ZIPK

    Molekulargewicht

    35 kDa

    Gen-ID

    1613

    NCBI Accession

    NP_001339

    UniProt

    O43293
Sie sind hier:
Chat with us!